2H-1,3,4-Oxadiazin-2-one,tetrahydro-3-[(2S,3S)-3-hydroxy-2-methyl-3-(2-naphthalenyl)-1-oxopropyl]-5-methyl-4-(1-methylethyl)-6-phenyl-, (5S,6R)- (652155-42-5)

Identification
Name:	2H-1,3,4-Oxadiazin-2-one,tetrahydro-3-[(2S,3S)-3-hydroxy-2-methyl-3-(2-naphthalenyl)-1-oxopropyl]-5-methyl-4-(1-methylethyl)-6-phenyl-, (5S,6R)-
CAS:	652155-42-5
Molecular Formula:	C₂₇H₃₀N₂O₄
Molecular Structure:
Properties
Safety Data

Other Product

2H-1,3,4-Oxadiazin-2-one,tetrahydro-3-[(2S,3S)-3-hydroxy-2-methyl-3-(1-naphthalenyl)-1-oxopropyl]-5-methyl-4-(1-methylethyl)-6-phenyl-, (5S,6R)-
2H-1,3,4-Oxadiazin-2-one,tetrahydro-3-[(2S,3S)-3-hydroxy-2-methyl-3-(4-nitrophenyl)-1-oxopropyl]-5-methyl-4-(1-methylethyl)-6-phenyl-, (5S,6R)-
2H-1,3,4-Oxadiazin-2-one,tetrahydro-3-[(2S,3S)-3-hydroxy-2-methyl-1-oxo-3-phenylpropyl]-5-methyl-4-(1-methylethyl)-6-phenyl-, (5S,6R)-
2H-1,3,4-Oxadiazin-2-one,tetrahydro-3-[(2S,3S)-3-hydroxy-1-oxo-4-(phenylmethoxy)-2-[(phenylthio)methyl]butyl]-5-methyl-4-(1-methylethyl)-6-phenyl-, (5S,6R)-
2H-1,3,4-Oxadiazin-2-one,tetrahydro-3-[(2S,3S)-3-hydroxy-2,4,4-trimethyl-1-oxopentyl]-5-methyl-4-(1-methylethyl)-6-phenyl-, (5S,6R)-
2H-1,3,4-Oxadiazin-2-one,tetrahydro-5-methyl-4-(1-methylethyl)-3-(1-oxopropyl)-6-phenyl-,(5S,6R)-
2H-1,3,4-Oxadiazin-2-one,tetrahydro-3-[(2S,3R)-3-hydroxy-2-methyl-1-oxo-5-phenyl-4-pentenyl]-5-methyl-4-(1-methylethyl)-6-phenyl-, (5S,6R)-
2H-1,3,4-Oxadiazin-2-one,tetrahydro-3-[(2S,3R)-3-hydroxy-2,4-dimethyl-1-oxopentyl]-5-methyl-4-(1-methylethyl)-6-phenyl-, (5S,6R)-
2H-1,3,4-Oxadiazin-2-one,tetrahydro-5-methyl-4-(1-methylethyl)-6-phenyl-, (5S,6R)-
2(5H)-Furanone,4-hydroxy-3-[(2R)-2-[(1R,2R,6S)-2-[(1E)-3-hydroxy-2-[(2S,3S,6R)-tetrahydro-3-methyl-6-[(1E)-3-[(2S,5S)-tetrahydro-5-[(1R)-1-methoxyethyl]-2-furanyl]-1-propen-1-yl]-2H-pyran-2-yl]-1-propen-1-yl]-6-methylcyclohexyl]-1-oxopropyl]-5-methylene-
2H-1,2,4-Oxadiazin-5(6H)-one,dihydro-2-methyl-4-[2-(1-methylethyl)phenyl]-3-thioxo-
2H-1,3,4-Oxadiazin-2-one,tetrahydro-5-methyl-6-phenyl-4-(2-phenylethyl)-, (5S,6R)-
2H-1,3,4-Oxadiazin-2-one,tetrahydro-4-(2-methoxyethyl)-5-methyl-6-phenyl-, (5S,6R)-
2H-1,3,4-Oxadiazin-2-one,tetrahydro-5-methyl-4-(2-phenoxyethyl)-6-phenyl-, (5S,6R)-
2H-1,3,4-Oxadiazin-2-one,tetrahydro-5-methyl-6-phenyl-4-[2-(phenylmethoxy)ethyl]-, (5S,6R)-
2H-1,3,4-Oxadiazin-2-one, tetrahydro-5-methyl-6-phenyl-4-propyl-,(5S,6R)-
2H-1,3,4-Oxadiazin-2-one,4-(2,2-dimethylpropyl)tetrahydro-5-methyl-6-phenyl-, (5S,6R)-
(2S,3S,4R,5R,6R)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyran-2-yl]oxy}
2(5H)-Furanone,4-hydroxy-3-[(2S)-2-[(1S,2S,6R)-2-[(1E)-3-hydroxy-2-[(2R,3R,6S)-tetrahydro-3-methyl-6-[(1E,3S)-3-[(2R,3S,5R)-tetrahydro-5-[(1S)-1-methoxyethyl]-3-methyl-2-furanyl]-1-buten-1-yl]-2H-pyran-2-yl]-1-propen-1-yl]-6-methylcyclohexyl]-1-oxopropyl]-,sodium salt (1:1)
2H-Pyran-2-one,tetrahydro-4-hydroxy-5-methyl-6-(1-methylethyl)-, (4S,5S,6R)-